COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates

COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates

BackgroundCOVID-19 vaccination reduces risk of SARS-CoV-2 infection, COVID-19 severity and death. However, the rate of seroconversion after COVID-19 vaccination in cancer patients requiring systemic anticancer treatment is poorly investigated. The aim of the present study was to determine the rate o...

Full description

Bibliographic Details
Main Authors: Georg C. Lodde, Melanie Fiedler, Ulf Dittmer, Jan-Malte Placke, Philipp Jansen, Jürgen C. Becker, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Wiebke Sondermann, Selma Ugurel
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Oncology
Subjects:
COVID-19 vaccination
seroconversion
skin cancer
immune checkpoint inhibition
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.879876/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.879876/full

Similar Items